Salvia miltiorrhiza: A source for anti-Alzheimers disease drugs

Pharmaceutical Biology

Volumn 54, Issue 1, 2016, Pages 18-24

  Zhang, Xiu Zhen ^a   Qian, Shao Song ^a   Zhang, Yue Jie ^a   Wang, Rui Qi ^a  

^a SHANDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Anti amyloid ; anti apoptosis; anti inflammation; antioxidant; multitarget; neurogenesis; neuroprotection

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; AMYLOID BETA PROTEIN ANTIBODY; CHOLINESTERASE INHIBITOR; CRYPTOTANSHINONE; DIHYDROTANSHINONE; DONEPEZIL; GALANTAMINE; NEW DRUG; PLANT MEDICINAL PRODUCT; RIVASTIGMINE; SALVIA MILTIORRHIZA EXTRACT; SALVIANIC BORNEOL ESTER; SALVIANOLIC ACID A; SALVIANOLIC ACID B; TACRINE; TANSHINONE I; TANSHINONE IIA; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT; PLANT EXTRACT;

ADVERSE DRUG REACTION; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHINESE MEDICINE; CHOLINESTERASE INHIBITION; DEGENERATIVE DISEASE; DRUG DEVELOPMENT; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFORMATION RETRIEVAL; MEDLINE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PREVALENCE; REVIEW; SALVIA MILTIORRHIZA; SCIENCEDIRECT; AMYLOID PLAQUE; ANIMAL; BRAIN; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYTOTHERAPY; PSYCHOLOGY; STRUCTURE ACTIVITY RELATION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS; MOLECULAR STRUCTURE; NEUROPROTECTIVE AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PLAQUE, AMYLOID; SALVIA MILTIORRHIZA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84949784723     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2015.1027408     Document Type: Review

References (77)

1. Akiyama H, Barger S, Barnum S, et al. (2000). Inflammation and Alzheimers disease. Neurobiol Aging 21: 383-421
2. Almeida S, Gascon E, Tran H, et al. (2013). Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC derived human neurons. Acta Neuropathol 126: 385-99
3. Bi XB, Deng YB, Gan DH, Wang YZ. (2008). Salvianolic acid B promotes survival of transplanted mesenchymal stem cells in spinal cord-injured rats. Acta Pharmacol Sin 29: 169-76
4. Bolognesi ML, Matera R, Minarini A, et al. (2009). Alzheimers disease: New approaches to drug discovery. Curr Opin Chem Biol 13: 303-8
5. Butterfield DA. (2002). Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimers disease brain: A review. Free Radic Res 36: 1307-13
6. Butterfield DA, Reed T, Newman SF, Sultana R. (2007). Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimers disease and mild cognitive impairment. Free Radic Biol Med 43: 658-77
7. Calabrese V, Cornelius C, Dinkova-Kostova AT, et al. (2010). Cellular stress responses, the hormesis paradigm, and vitagenes: Novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal 13: 1763-811
8. Cao YY, Wang L, Ge H, et al. (2013). Salvianolic acid A, a polyphenolic derivative from Salvia miltiorrhiza Bunge, as a multifunctional agent for the treatment of Alzheimers disease. Mol Divers 17: 515-24
9. Chen J, Wang F, Lee FS, et al. (2006). Separation and identification of water-soluble salvianolic acids from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography and ESI-MS analysis. Talanta 69: 172-9
10. Chen JX, Wang SR, Zhao MJ, et al. (2003). Effect of different drug dosage to activate blood circulation and to nourish qi on cardiac function and structure of congestive heart failure rats after acute myocardial infarction. Zhongguo Zhong Yao Za Zhi 28: 446-9
11. Chen TH, Hsu YT, Chen CH, et al. (2007). Tanshinone IIA from Salvia miltiorrhiza induces heme oxygenase-1 expression and inhibits lipopolysaccharide-induced nitric oxide expression in RAW 264.7 cells. Mitochondrion 7: 101-5
12. Chen Y, Wu X, Yu S, et al. (2012). Neuroprotective capabilities of Tanshinone IIA against cerebral ischemia/reperfusion injury via anti-apoptotic pathway in rats. Biol Pharm Bull 35: 164-70
13. Choi HS, Cho DI, Choi HK, et al. (2004). Molecular mechanisms of inhibitory activities of tanshinones on lipopolysaccharide-induced nitric oxide generation in RAW 264.7 cells. Arch Pharm Res 27: 1233-7
14. Chong CM, Zhou ZY, Razmovski-Naumovski V, et al. (2013). Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Neurosci Lett 543: 121-5
15. Coyle JT, Price DL, DeLong MR. (1983). Alzheimers disease: A disorder of cortical cholinergic innervation. Science 219: 1184-90
16. Cummings JL. (2004). Alzheimers disease. N Engl J Med 351: 56-67
17. Durairajan SS, Yuan Q, Xie L, et al. (2008). Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty. Neurochem Int 52: 741-50
18. Eriksson PS, Perfilieva E, Bjork-Eriksson T, et al. (1998). Neurogenesis in the adult human hippocampus. Nat Med 4: 1313-17
19. Fan GW, Gao XM, Wang H, et al. (2009). The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. J Steroid Biochem Mol Biol 113: 275-80
20. Fernandez AP, Pozo-Rodrigalvarez A, Serrano J, Martinez-Murillo R. (2010). Nitric oxide: Target for therapeutic strategies in Alzheimers disease. Curr Pharm 16: 2837-50
21. Guo G, Li B, Wang Y, et al. (2010). Effects of salvianolic acid B on proliferation, neurite outgrowth and differentiation of neural stem cells derived from the cerebral cortex of embryonic mice. Sci China Life Sci 53: 653-62
22. Haass C. (2004). Take five-BACE and the gamma-secretase quartet conduct Alzheimers amyloid beta-peptide generation. EMBO J 23: 483-8
23. Han M, Liu Y, Zhang B, et al. (2011). Salvianic borneol ester reduces beta-amyloid oligomers and prevents cytotoxicity. Pharm Biol 49: 1008-13
24. Hansen RA, Gartlehner G, Webb AP, et al. (2008). Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimers disease: A systematic review and meta-analysis. Clin Interv Aging 3: 211-25
25. Hardy J, Selkoe DJ. (2002). The amyloid hypothesis of Alzheimers disease: Progress and problems on the road to therapeutics. Science 297: 353-6
26. Helmuth L. New therapies. (2002). New Alzheimers treatments that may ease the mind. Science 297: 1260-2
27. Hu L, Yu J, Li F, et al. (2011). Effects of Salvia miltorrhiza in neural differentiation of rat mesenchymal stem cells with optimized protocol. J Ethnopharmacol 136: 334-40
28. Huebbe P, Schaffer S, Jofre-Monseny L, et al. (2007). Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation. Mol Nutr Food Res 51: 1510-17
29. Ji HF, Zhang HY. (2008). Multipotent natural agents to combat Alzheimers disease. Functional spectrum and structural features. Acta Pharmacol Sin 29: 143-51
30. Jiang WY, Jeon BH, Kim YC, et al. (2013). PF2401-SF, standardized fraction of Salvia miltiorrhiza shows anti-inflammatory activity in macrophages and acute arthritis in vivo. Int Immunopharmacol 16: 160-4
31. Jin DZ, Yin LL, Ji XQ, Zhu XZ. (2006). Cryptotanshinone inhibits cyclooxygenase-2 enzyme activity but not its expression. Eur J Pharmacol 549: 166-72
32. Joe Y, Zheng M, Kim HJ, et al. (2012). Salvianolic acid B exerts vasoprotective effects through the modulation of heme oxygenase-1 and arginase activities. J Pharmacol Exp Ther 341: 850-8
33. Kim D, Tsai LH. (2009). Bridging physiology and pathology in AD. Cell 137: 997-1000
34. Kim DH, Jeon SJ, Jung JW, et al. (2007). Tanshinone congeners improve memory impairments induced by scopolamine on passive avoidance tasks in mice. Eur J Pharmacol 574: 140-7
35. Kim DH, Park SJ, Kim JM, et al. (2011). Cognitive dysfunctions induced by a cholinergic blockade and Abeta 25-35 peptide are attenuated by salvianolic acid B. Neuropharmacology 61: 1432-40
36. Lee MS, Kwon YT, Li M, et al. (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405: 360-4
37. Lee SE, Jeong SI, Yang H, et al. (2012). Extract of Salvia miltiorrhiza (Danshen) induces Nrf2-mediated heme oxygenase-1 expression as a cytoprotective action in RAW 264.7 macrophages. J Ethnopharmacol 139: 541-8
38. Lee YW, Kim DH, Jeon SJ, et al. (2013). Neuroprotective effects of salvianolic acid B on an Aβ 25-35 peptide-induced mouse model of Alzheimers disease. Eur J Pharmacol 704: 70-7
39. Limke TL, Rao MS. (2002). Neural stem cells in aging and disease. J Cell Mol Med 6: 475-96
40. Lin YH, Liu AH, Wu H, et al. (2006). Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents Abeta(25-35)-induced reduction in BPRP in PC12 cells. Biochem Biophys Res Commun 348: 593-9
41. Liu CS, Chen NH, Zhang JT. (2007). Protection of PC12 cells from hydrogen peroxide-induced cytotoxicity by salvianolic acid B, a new compound isolated from Radix Salviae miltiorrhizae. Phytomedicine 14: 492-7
42. Liu J, Yang CF, Wasser S, et al. (2001). Protection of Salvia miltiorrhiza against aflatoxin-B1-induced hepatocarcinogenesis in Fischer 344 rats dual mechanisms involved. Life Sci 69: 309-26
43. Liu T, Jin H, Sun QR, et al. (2010). The neuroprotective effects of tanshinone IIA on beta-amyloid-induced toxicity in rat cortical neurons. Neuropharmacology 59: 595-604
44. Liu XJ, Wu WT. (1999). Effects of ligustrazine, tanshinone II A, ubiquinone, and idebenone on mouse water maze performance. Zhongguo Yao Li Xue Bao 20: 987-90
45. Mattson MP. (1997). Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77: 81-132
46. Mei Z, Situ B, Tan X, et al. (2010). Cryptotanshinione upregulates alpha-secretase by activation PI3K pathway in cortical neurons. Brain Res 1348: 165-73
47. Mei Z, Yan P, Situ B, et al. (2012). Cryptotanshinione inhibits beta-amyloid aggregation and protects damage from beta-amyloid in SH-SY5Y cells. Neurochem Res 37: 622-8
48. Mei Z, Zhang F, Tao L, et al. (2009). Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro. Neurosci Lett 452: 90-5
49. Mildner A, Schlevogt B, Kierdorf K, et al. (2011). Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimers disease. J Neurosci 31: 11159-71
50. Mimura T, Dezawa M, Kanno H, Yamamoto I. (2005). Behavioral and histological evaluation of a focal cerebral infarction rat model transplanted with neurons induced from bone marrow stromal cells. J Neuropathol Exp Neurol 64: 1108-17
51. Mott RT, Hulette CM. (2005). Neuropathology of Alzheimers disease. Neuroimaging Clin N Am 15: 755-65, ix
52. Qian YH, Xiao Q, Xu J. (2012). The protective effects of tanshinone IIA on beta-amyloid protein (1-42)-induced cytotoxicity via activation of the Bcl-xL pathway in neuron. Brain Res Bull 88: 354-8
53. Radak Z, Zhao Z, Goto S, Koltai E. (2011). Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA. Mol Aspects Med 32: 305-15
54. Ren G, Fan X, Liang Q, et al. (2013). Screening and evaluation of traditional Chinese medicine by microarray expression analysis. J Ethnopharmacol 147: 564-9
55. Ren Y, Houghton PJ, Hider RC, Howes J. (2004). Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza. Planta Med 70: 201-4
56. Shi LL, Yang WN, Chen XL, et al. (2012). The protective effects of tanshinone IIA on neurotoxicity induced by beta-amyloid protein through calpain and the p35/Cdk5 pathway in primary cortical neurons. Neurochem Int 61: 227-35
57. Shu T, Pang M, Rong L, et al. (2014). Effects of Salvia miltiorrhiza on neural differentiation of induced pluripotent stem cells. J Ethnopharmacol 153: 233-41
58. Su JH, Anderson AJ, Cummings BJ, Cotman CW. (1994). Immunohistochemical evidence for apoptosis in Alzheimers disease. Neuroreport 5: 2529-33
59. Taylor CJ, Ireland DR, Ballagh I, et al. (2008). Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory. Neurobiol Dis 31: 250-60
60. Tian LL, Wang XJ, Sun YN, et al. (2008). Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells. Int J Biochem Cell Biol 40: 409-22
61. Togo T, Katsuse O, Iseki E. (2004). Nitric oxide pathways in Alzheimers disease and other neurodegenerative dementias. Neurol Res 26: 563-6
62. Yagami T, Ueda K, Asakura K, et al. (2002). Gas6 rescues cortical neurons from amyloid protein-induced apoptosis. Neuropharmacology 43: 1289-96
63. Yang J, Yan Y, Ciric B, et al. (2010). Evaluation of bone marrow-and brain-derived neural stem cells in therapy of central nervous system autoimmunity. Am J Pathol 177: 1989-2001
64. Yu H, Yao L, Zhou H, et al. (2014). Neuroprotection against Aβ25-35-induced apoptosis by Salvia miltiorrhiza extract in SH-SY5Y cells. Neurochem Int 75: 89-95
65. Yu PF, Wang WY, Eerdun G, et al. (2011). The role of P-glycoprotein in transport of danshensu across the blood-brain barrier. Evid Based Complement Alternat Med 2011: 713523
66. Wang Q, Yu X, Patal K, et al. (2013). Tanshinones inhibit amyloid aggregation by amyloid-beta peptide, disaggregate amyloid fibrils, and protect cultured cells. ACS Chem Neurosci 4: 1004-15
67. Wang X, Morris-Natschke SL, Lee KH. (2007). New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 27: 133-48
68. Wang XJ, Xu JX. (2005). Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. Neurosci Res 51: 129-38
69. Watkins PB, Zimmerman HJ, Knapp MJ, et al. (1994). Hepatotoxic effects of tacrine administration in patients with Alzheimers disease. JAMA 271: 992-8
70. Whitehouse PJ, Price DL, Clark AW, et al. (1981). Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10: 122-6
71. Wisniewski HM, Barcikowska M, Kida E. (1991). Phagocytosis of beta/A4 amyloid fibrils of the neuritic neocortical plaques. Acta Neuropathol 81: 588-90
72. Wong KK, Ho MT, Lin HQ, et al. (2010). Cryptotanshinone, an acetylcholinesterase inhibitor from Salvia miltiorrhiza, ameliorates scopolamine-induced amnesia in Morris water maze task. Planta Med 76: 228-34
73. Zhang F, Zheng W, Pi R, et al. (2009). Cryptotanshinone protects primary rat cortical neurons from glutamate-induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. Exp Brain Res 193: 109-18
74. Zhang N, Kang T, Xia Y, et al. (2012). Effects of salvianolic acid B on survival, self-renewal and neuronal differentiation of bone marrow derived neural stem cells. Eur J Pharmacol 697: 32-9
75. Zhong GX, Li P, Zeng LJ, et al. (2009). Chemical characteristics of Salvia miltiorrhiza (Danshen) collected from different locations in China. J Agric Food Chem 57: 6879-87
76. Zhou L, Zuo Z, Chow MS. (2005). Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45: 1345-59
77. Zhuang P, Zhang Y, Cui G, et al. (2012). Direct stimulation of adult neural stem/progenitor cells in vitro and neurogenesis in vivo by salvianolic acid B. PLoS One 7: e35636